Epiontis
Founded Year
2003Stage
Acquired | AcquiredMissing: Epiontis's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Epiontis's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Epiontis Patents
Epiontis has filed 26 patents.
The 3 most popular patent topics include:
- Clusters of differentiation
- Transcription factors
- Immune system
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
10/24/2018 | 3/7/2023 | Transcription factors, Small nuclear RNA, Clusters of differentiation, Molecular biology, Immune system | Grant |
Application Date | 10/24/2018 |
|---|---|
Grant Date | 3/7/2023 |
Title | |
Related Topics | Transcription factors, Small nuclear RNA, Clusters of differentiation, Molecular biology, Immune system |
Status | Grant |
Latest Epiontis News
Aug 2, 2018
Premium NEW YORK (GenomeWeb) – German epigenetic technology company Epiontis and collaborators this week published a seminal study demonstrating the power of Epiontis' immune cell counting platform, laying early groundwork for the potential development of clinical assays. Get the full story with GenomeWeb Premium *Before your trial expires, we’ll put together a custom quote with your long-term premium options. Not ready for premium? Qiagen This webinar will present the results of an evaluation of a web-based variant interpretation software system for clinical next-generation sequencing. Aug Agena Bioscience In this two-part webinar, Dr. Elin Gray, from Edith Cowan University, and Ms. Weiwei Zhao, from Kingmed diagnostic, will compare the highly sensitive, multiplexed UltraSEEK technology, on the MassARRAY system, to digital droplet PCR (ddPCR) results on melanoma and non-small cell lung carcinoma samples. Aug
Epiontis Frequently Asked Questions (FAQ)
When was Epiontis founded?
Epiontis was founded in 2003.
Where is Epiontis's headquarters?
Epiontis's headquarters is located at Rudower Chaussee 29, Berlin.
What is Epiontis's latest funding round?
Epiontis's latest funding round is Acquired.
Who are the investors of Epiontis?
Investors of Epiontis include Precision Medicine Group.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.